A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Spinal cord lesions are more commonly seen in progressive forms of multiple sclerosis, and they can result in an increased risk of disability. In relapsing-remitting MS, which 80 to 85 percent of ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, ...

Multiple Sclerosis Research News. June 28, 2025. Top Headlines . The Common Blood Test That Predicts How Fast Alzheimer’s Hits. June 22, 2025 ...

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement ...

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Spinal cord injury leads to lasting motor and sensory loss, with limited treatment options. Here, the authors show that subdural electric field stimulation delivered across the injury via an ultra ...

When it's time to talk with your doctor about primary progressive multiple sclerosis (PPMS), you may not know where to begin. Discover 11 important questions you can ask to get the conversation ...

Multiple system atrophy (MSA) is a fatal, adult-onset neurodegenerative disorder of uncertain etiology, clinically characterized by various combinations of Levo-dopa-unresponsive parkinsonism, and ...

European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, ... Roche is investigating more than a dozen medicines for neurological disorders, ...